| Bibliographic Citation
| - Michallet Anne-Sophie, Letestu Rémi, Le Garff-Tavernier Magali, Aanei Carmen, Ticchioni Michel, Dilhuydy Marie-Sarah, Subtil Fabien, Rouille Valerie, Mahe Beatrice, Laribi Kamel, Villemagne Bruno, Salles Gilles, Tournilhac Olivier, Delmer Alain, Portois Christelle, Pegourie Brigitte, Leblond Veronique, Tomowiak Cecile, De Guibert Sophie, Orsini Piocelle Frederique, Banos Anne, Carassou Philippe, Cartron Guillaume, Fornecker Luc-Matthieu, Ysebaert Loic, Dartigeas Caroline, Truchan-Graczyk Malgorzata, Vilque Jean-Pierre, Aurran Thérèse, Cymbalista Florence, Lepretre Stéphane, Levy Vincent, Nguyen-Khac Florence, Feugier Pierre. A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial. Blood, American Society of Hematology, 2021, 137 (8), pp.1019-1023. ⟨10.1182/blood.2020008164⟩
- Michallet Anne-Sophie, Letestu Rémi, Le Garff-Tavernier Magali, Aanei Carmen, Ticchioni Michel, Dilhuydy Marie-Sarah, Subtil Fabien, Rouille Valerie, Mahe Beatrice, Laribi Kamel, Villemagne Bruno, Salles Gilles, Tournilhac Olivier, Delmer Alain, Portois Christelle, Pegourie Brigitte, Leblond Veronique, Tomowiak Cecile, de Guibert Sophie, Orsini Piocelle Frederique, Banos Anne, Carassou Philippe, Cartron Guillaume, Fornecker Luc-Matthieu, Ysebaert Loic, Dartigeas Caroline, Truchan-Graczyk Malgorzata, Vilque Jean-Pierre, Aurran Thérèse, Cymbalista Florence, Lepretre Stéphane, Levy Vincent, Nguyen-Khac Florence, Feugier Pierre . A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial . Blood, 2021, 137 (8), pp.1019-1023 . ⟨10.1182/blood.2020008164⟩
- Michallet Anne-Sophie, Letestu Rémi, Le Garff-Tavernier Magali, Aanei Carmen, Ticchioni Michel, Dilhuydy Marie-Sarah, Subtil Fabien, Rouille Valerie, Mahe Beatrice, Laribi Kamel, Villemagne Bruno, Salles Gilles, Tournilhac Olivier, Delmer Alain, Portois Christelle, Pegourie Brigitte, Leblond Veronique, Tomowiak Cecile, de Guibert Sophie, Orsini Piocelle Frederique, Banos Anne, Carassou Philippe, Cartron Guillaume, Fornecker Luc-Matthieu, Ysebaert Loic, Dartigeas Caroline, Truchan-Graczyk Malgorzata, Vilque Jean-Pierre, Aurran Thérèse, Cymbalista Florence, Lepretre Stéphane, Levy Vincent, Nguyen-Khac Florence, Feugier Pierre. A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial. Blood, 2021, 137 (8), pp.1019-1023. ⟨10.1182/blood.2020008164⟩
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
